Literature DB >> 24203601

Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV.

R N Lucille Sanzero Eller1.   

Abstract

Investigations in both healthy and clinical populations support the effectiveness of cognitive-behavioral interventions for immune enhancement and symptom reduction. However, there is a paucity of research examining these interventions in human immunodeficiency virus (HIV) positive populations, and existing studies lack precision in design. In this study, HIV seropositive subjects, blocked by illness stage, were randomized to a guided imagery (N=23) or progressive muscle relaxation (PMR) (N=22) treatment, or a control group (N = 24). The six-week treatments were delivered via audiotape following brief face-to-face instruction, and effects on fatigue, depression, and three measures of cellular immunity were examined. Pre and posttreatment measures included the Center for Epidemiologic Studies Depression Scale (CES-D), Sleep and Rest subscale of the Sickness Impact Profile (SIP), CD4+ and CD16+ lymphocyte numbers, and CD4+:CD8 + T lymphocyte ratio. Data were analyzed using a hierarchical multiple regression model, holding pretreatment effects constant while assessing the contribution of each treatment to the dependent variables. The guided imagery group had a significant decrease in depression and fatigue, while the PMR group demonstrated an increased CD4+ T lymphocyte count and a reduction in depression. Findings supported the effectiveness of both interventions for symptom alleviation, and of PMR for immune enhancement in persons with HIV, and suggest a differential effect for the two treatments in this population.

Entities:  

Year:  1995        PMID: 24203601     DOI: 10.1007/BF02888599

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  42 in total

1.  Effect of psychological intervention in the form of relaxation and guided imagery on cellular immune function in normal healthy subjects. An overview.

Authors:  R Zachariae; J S Kristensen; P Hokland; J Ellegaard; E Metze; M Hokland
Journal:  Psychother Psychosom       Date:  1990       Impact factor: 17.659

2.  Neuropeptides and their receptors: a psychosomatic network.

Authors:  C B Pert; M R Ruff; R J Weber; M Herkenham
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

3.  Identifying major concerns of persons with acquired immunodeficiency syndrome: a replication.

Authors:  M B Longo; J A Spross; A M Locke
Journal:  Clin Nurse Spec       Date:  1990       Impact factor: 1.067

4.  Stress reduction training changed number of sexual partners but not immune function in men with HIV.

Authors:  T J Coates; L McKusick; R Kuno; D P Stites
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

5.  Enkephalins and T-cell enhancement in normal volunteers and cancer patients.

Authors:  N P Plotnikoff; G C Miller; N Nimeh; R E Faith; A J Murgo; J Wybran
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

6.  Immunologic properties of methionine-enkephalin, and therapeutic implications in AIDS, ARC, and cancer.

Authors:  J Wybran; L Schandené; J P Van Vooren; G Vandermoten; D Latinne; J Sonnet; M De Bruyère; H Taelman; N P Plotnikoff
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

7.  Depression, distress, lymphocyte subsets, and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men.

Authors:  J G Rabkin; J B Williams; R H Remien; R Goetz; R Kertzner; J M Gorman
Journal:  Arch Gen Psychiatry       Date:  1991-02

8.  Application of psychoimmunotherapy in patients with alopecia universalis.

Authors:  H Teshima; H Sogawa; K Mizobe; N Kuroki; T Nakagawa
Journal:  Psychother Psychosom       Date:  1991       Impact factor: 17.659

9.  Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the Multicenter AIDS Cohort Study.

Authors:  R A Kaslow; J P Phair; H B Friedman; D Lyter; R E Solomon; J Dudley; B F Polk; W Blackwelder
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

10.  Structured group intervention model for AIDS patients.

Authors:  F I Fawzy; S Namir; D L Wolcott
Journal:  Psychiatr Med       Date:  1989
View more
  7 in total

1.  Effects of spiritual mantram repetition on HIV outcomes: a randomized controlled trial.

Authors:  Jill E Bormann; Allen L Gifford; Martha Shively; Tom L Smith; Laura Redwine; Ann Kelly; Sheryl Becker; Madeline Gershwin; Patricia Bone; Wendy Belding
Journal:  J Behav Med       Date:  2006-07-18

Review 2.  Guided imagery as a treatment option for fatigue: a literature review.

Authors:  Victoria Menzies; Nancy Jallo
Journal:  J Holist Nurs       Date:  2011-07-19

3.  Mind-Body Medicine and Immune System Outcomes: A Systematic Review.

Authors:  Helané Wahbeh; Ashley Haywood; Karen Kaufman; Heather Zwickey
Journal:  Open Complement Med J       Date:  2009

Review 4.  Effects of psychological interventions on neuroendocrine hormone regulation and immune status in HIV-positive persons: a review of randomized controlled trials.

Authors:  Adam W Carrico; Michael H Antoni
Journal:  Psychosom Med       Date:  2008-06       Impact factor: 4.312

5.  Stress management interventions for HIV+ adults: a meta-analysis of randomized controlled trials, 1989 to 2006.

Authors:  Lori A J Scott-Sheldon; Seth C Kalichman; Michael P Carey; Robyn L Fielder
Journal:  Health Psychol       Date:  2008-03       Impact factor: 4.267

6.  Mind-body practices for people living with HIV: a systematic scoping review.

Authors:  Maria Pilar Ramirez-Garcia; Marie-Pier Gagnon; Sébastien Colson; José Côté; Jorge Flores-Aranda; Myriam Dupont
Journal:  BMC Complement Altern Med       Date:  2019-06-11       Impact factor: 3.659

Review 7.  Cognitive-behavioural interventions for mood and anxiety disorders in HIV: a systematic review.

Authors:  G Spies; L Asmal; S Seedat
Journal:  J Affect Disord       Date:  2013-05-17       Impact factor: 4.839

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.